Histone deacetylase inhibitors as therapeutic agents for Niemann-Pick type C disease
Patent
Description
Embodiments herein relate to the field of lysosomal storage disorders, and, more specifically, to methods of treating lysosomal storage disorders such as Niemann-Pick type C disease, for instance with inhibitors of histone deacetylases, particularly inhibitors of class 1 histone deacetylases. In various embodiments, methods of treating Niemann-Pick type C disease with inhibitors of class 1 histone deacetylases are described.
Attributes
Attribute Name | Values |
Title |
|
Patent Number |
|
USPTO Link |
|
Inventor |
Olaf G. Wiest
Frederick R. Maxfield
Paul Helquist
|
Inventor From Local Institution |
Olaf G. Wiest
Paul Helquist
|
Other Application |
|
Prior Publication Date |
|
Prior Publication Number |
|
Claims |
|
Cooperative Patent Classification codes |
|
International Patent Classification codes |
|
Language |
|
Date Issued |
|
Publisher |
|
Assignee |
|
Record Visibility and Access |
Public
|
Content License |
|
Departments and Units |
|
Member of |
|